MedPath

Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study.

Phase 4
Conditions
Acute Myocardial Infarction
Registration Number
NCT01914055
Lead Sponsor
Ospedale San Donato
Brief Summary

demonstrate that FD-OCT guidance is feasible and possibly results in reduction of frequency-domain Optical Coherence Tomography-defined residual thrombus burden after thrombus-aspiration.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • ST elevation myocardial infarction
  • Ages Eligible for Study: >18 years old
  • Genders Eligible for Study: Both (female sex with child-bearing potential excluded)
Exclusion Criteria
  • occluded (TIMI 0) or sub occluded (TIMI 1) proximal vessel of estimated diameter ≥3mm
  • intended use of thrombus aspiration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
number of cross-sections with thrombus area more than 10% at post-stenting frequency-domain (FD) Optical Coherence Tomographywithin the primary PCI procedure

Whether FD-OCT guidance of manual thrombus aspiration (TA) is superior to conventional angio-guided TA in reducing residual thrombus burden after stenting (defined as the number of cross-sections with thrombus area more than 10% at post-stenting FD-OCT)

Secondary Outcome Measures
NameTimeMethod
major adverse cardiac eventsat 6 months

rate of major adverse cardiac events at 6 months from the index procedure

Trial Locations

Locations (1)

Cardiovascular Department, Ospedale S.Donato

🇮🇹

Arezzo, AR, Italy

Cardiovascular Department, Ospedale S.Donato
🇮🇹Arezzo, AR, Italy
Leonardo Bolognese
Contact
leonardobolognese@hotmail.com
Leonardo Bolognese, MD, FESC
Principal Investigator
Giovanni Falsini, MD
Sub Investigator
Paolo Angioli, MD
Sub Investigator
Kenneth Ducci, MD
Sub Investigator
Francesco Liistro, MD
Sub Investigator
Simone Grotti, MD
Sub Investigator
Italo Porto, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.